search
Back to results

The Effect of Vegetarian Diet on Patients With Metabolic Associated Fatty Liver Disease

Primary Purpose

Metabolism and Nutrition Disorder, Liver Diseases, Obesity

Status
Not yet recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
dietary intervention
Sponsored by
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Metabolism and Nutrition Disorder focused on measuring Metabolism associated fatty liver disease, Obesity, Vegetarian diet, diet intervention

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Clinically diagnosed as fatty liver, and BMI≥24.0kg/m²;
  2. 18-60 years old;
  3. Have not received drug treatment if having hyperglycemia, hyperlipidemia and high uric acid ;
  4. No antibiotics in the last 1 month;
  5. The guardian's informed consent;

Exclusion Criteria:

  1. Have received drug treatment of fatty liver disease within three months;
  2. Patients with with liver cirrhosis, viral hepatitis and other liver diseases;
  3. Patients with serious heart, lung, kidney diseases and patients with cancer;
  4. Pregnant and nursing women;
  5. Other conditions that may affect the results of the study

Sites / Locations

  • Department of Clinical Nutrition, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention group

Control group

Arm Description

Participations in this group are required to follow a healthy vegetarian diet (avoid meat, poultry, fish, dairy) during the 24-weeks trail. Daily energy intake = BMR(basal metabolic rate) × 1.25-500kcal;BMR = 370 + 21.6 × Lean body mass(kg) Requirements of energy supply ratio: protein 15%-20%; fat 20%-25%; carbohydrate 50%-60%.

Participations in this group are required to follow a healthy omnivorous diet (No restriction on food sources) during the 24-weeks trail. Daily energy intake = BMR × 1.25-500kcal;BMR = 370 + 21.6 × Lean body mass(kg) Requirements of energy supply ratio: protein 15%-20%; fat 20%-25%; carbohydrate 50%-60%.

Outcomes

Primary Outcome Measures

The primary outcome was the weight of fat mass after 24 weeks intervention.
Weight loss, especially the reduction of body fat mass, is the most important treatment for the prevention and treatment of MAFLD and its complicationsIn our study, we will measure weight of fat mass using a body composition analyzer (Biospace Inbody 720, Korea) at the baseline and after 24-week intervention. The difference in the weight of fat mass after intervention between the two groups is the primary outcome.

Secondary Outcome Measures

Results of B-ultrasonic examination and Fibroscan examination
Imaging examination results are an important basis for the clinical diagnosis of NAFLD, which can show the degree of hepatic steatosis and hepatic fibrosis. Imaging findings of MAFLD will be measured and compared at the baseline and end of our study.
The changes of serum alanine aminotransferase (ALT) at week 24 intervention from the baseline
Hepatic steatosis is often accompanied by changes in hepatic enzymes.
The changes of serum aspartate aminotransferase (AST) at week 24 intervention from the baseline
Hepatic steatosis is often accompanied by changes in hepatic enzymes.
24-week weight change
The 24-week intervention is expected to bring weight loss. We will compare the weight loss between the two groups

Full Information

First Posted
May 23, 2022
Last Updated
July 1, 2022
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT05443581
Brief Title
The Effect of Vegetarian Diet on Patients With Metabolic Associated Fatty Liver Disease
Official Title
The Effect of Vegetarian Diet on Patients With Metabolic Associated Fatty Liver Disease:A Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 1, 2022 (Anticipated)
Primary Completion Date
May 2024 (Anticipated)
Study Completion Date
May 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In this study, 18-60 years old patients with metabolic associated fatty liver disease(MAFLD) will be recruited to test the intervention effect of vegetarian diet. This randomized clinical trial randomized individuals to a healthy vegetarian diet or a healthy omnivorous diet for 24 weeks. At the baseline and after the 24week intervention, the clinical manifestations of MAFLD, obesity levels, indices for glucose and lipid metabolism parameters, results of questionnaire and fecal samples will be collected and analyzed.
Detailed Description
Dietary control remains an important way for nutritional intervention of metabolic related fatty liver disease. However, studies shows that patients have low compliance to the traditional diet. The topic proposed based on previous studies,recruiting of 220 obesity patients with metabolic associated fatty liver disease aged 18-60. After the informed consent, they will be randomly divided into intervention group and control group, intervention group will be given healthy vegetarian diet intervention and the control group given healthy omnivorous diet. Both diets are in line with the principles of fatty liver treatment. Interventions consisted primarily of face-to -face interview monthly and online interview every 2 weeks, which will be performed by professional dietitians. All participants were asked not to alter their exercise patterns during the study period. The primary outcome was the weight of fat mass after 24 weeks intervention. Secondary outcomes included imaging findings (B-ultrasonic examination and Fibroscan) of MAFLD, liver function, anthropometric measures, plasma lipid and glucose levels. At the meantime, serum oxidative stress indices, results of compliance survey and metabolites of Intestinal flora will be collected and analyzed. Through the above detection of the indicators related to MAFLD and obesity, it is explored whether the vegetarian diet can be an efficient and feasible way to the nutritional therapy of MAFLD.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Metabolism and Nutrition Disorder, Liver Diseases, Obesity, Diet, Healthy
Keywords
Metabolism associated fatty liver disease, Obesity, Vegetarian diet, diet intervention

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
220 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention group
Arm Type
Experimental
Arm Description
Participations in this group are required to follow a healthy vegetarian diet (avoid meat, poultry, fish, dairy) during the 24-weeks trail. Daily energy intake = BMR(basal metabolic rate) × 1.25-500kcal;BMR = 370 + 21.6 × Lean body mass(kg) Requirements of energy supply ratio: protein 15%-20%; fat 20%-25%; carbohydrate 50%-60%.
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
Participations in this group are required to follow a healthy omnivorous diet (No restriction on food sources) during the 24-weeks trail. Daily energy intake = BMR × 1.25-500kcal;BMR = 370 + 21.6 × Lean body mass(kg) Requirements of energy supply ratio: protein 15%-20%; fat 20%-25%; carbohydrate 50%-60%.
Intervention Type
Behavioral
Intervention Name(s)
dietary intervention
Intervention Description
Dietary guidance will be given to participants through monthly face-to-face interviews and biweekly telephone calls to change their dietary structure and energy intake.
Primary Outcome Measure Information:
Title
The primary outcome was the weight of fat mass after 24 weeks intervention.
Description
Weight loss, especially the reduction of body fat mass, is the most important treatment for the prevention and treatment of MAFLD and its complicationsIn our study, we will measure weight of fat mass using a body composition analyzer (Biospace Inbody 720, Korea) at the baseline and after 24-week intervention. The difference in the weight of fat mass after intervention between the two groups is the primary outcome.
Time Frame
24 weeks
Secondary Outcome Measure Information:
Title
Results of B-ultrasonic examination and Fibroscan examination
Description
Imaging examination results are an important basis for the clinical diagnosis of NAFLD, which can show the degree of hepatic steatosis and hepatic fibrosis. Imaging findings of MAFLD will be measured and compared at the baseline and end of our study.
Time Frame
24 weeks
Title
The changes of serum alanine aminotransferase (ALT) at week 24 intervention from the baseline
Description
Hepatic steatosis is often accompanied by changes in hepatic enzymes.
Time Frame
24 weeks
Title
The changes of serum aspartate aminotransferase (AST) at week 24 intervention from the baseline
Description
Hepatic steatosis is often accompanied by changes in hepatic enzymes.
Time Frame
24 weeks
Title
24-week weight change
Description
The 24-week intervention is expected to bring weight loss. We will compare the weight loss between the two groups
Time Frame
24 weeks
Other Pre-specified Outcome Measures:
Title
The Results of compliance survey will be collected every month.
Description
We have designed a compliance scale to evaluate the compliance , which may be important to advise the nutritionists and doctors about the prevention and treatment of MAFLD.
Time Frame
24 weeks
Title
The difference of serum superoxide dismutase (SOD) level between two groups after 24-week intervention
Description
Cause vegetarian diet may contain more phytochemicals and less saturated fat and cholesterol due to the plant-based nature of the diet, resulting in better metabolic status and milder metabolic burden,we have presumed that the serum SOD level be different between two groups at the end of study.
Time Frame
24 weeks
Title
The difference of metabolites of Intestinal flora between two groups after 24-week intervention.
Description
The fecal samples before and after the intervention to examine the effect of vegetarian diets on gut microbiota metabolites.
Time Frame
24 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinically diagnosed as fatty liver, and BMI≥24.0kg/m²; 18-60 years old; Have not received drug treatment if having hyperglycemia, hyperlipidemia and high uric acid ; No antibiotics in the last 1 month; The guardian's informed consent; Exclusion Criteria: Have received drug treatment of fatty liver disease within three months; Patients with with liver cirrhosis, viral hepatitis and other liver diseases; Patients with serious heart, lung, kidney diseases and patients with cancer; Pregnant and nursing women; Other conditions that may affect the results of the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Xiuhua Shen, Professor
Phone
+86-139-1691-0428
Email
srachel@126.com
First Name & Middle Initial & Last Name or Official Title & Degree
Kaijie Xu, Master
Phone
+86-150-2668-6958
Email
kaijie111xu@126.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xiuhua Shen, Professor
Organizational Affiliation
Xinhua Hospital Afflicated to Shanghai Jiaotong University of Medicin
Official's Role
Study Chair
Facility Information:
Facility Name
Department of Clinical Nutrition, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200092
Country
China

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Effect of Vegetarian Diet on Patients With Metabolic Associated Fatty Liver Disease

We'll reach out to this number within 24 hrs